Resources Contact Us Home
Modified leukotoxin protein

Image Number 15 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Flash drive
Method and device for the detection of defects or correction of defects in machines
ESD protection circuit and ESD protection device thereof
Hypallergenic mosaic antigens and methods of making same
Disk drive
Decoding and presentation time stamps for MPEG-4 advanced video coding
Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
  Randomly Featured Patents
Double functional exercise bike for exercise and training
Cannabinoid receptor ligands and uses thereof
Rack aligning fixture and method of its use
Display panel and method of manufacturing the same
Magneto-optical recording medium, method of recording and reproducing information in and from said magneto-optical recording medium and method of producing said mageto-optical recording medium
Photosensitive polymer compositions comprising polyether-ester amides
Method and device for compensating for partial hearing loss
Latex modified pulp insulated conductors
Paper cutting device
File cloning across different filesets